Track topics on Twitter Track topics that are important to you
(Reuters) - The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp, Mylan NV, Gilead Sciences and Novartis AG, who the regulator says are potentially blocking access to samples of their drugs to delay generic comp...
Original Article: FDA names drugmakers likely blocking access to drug samplesNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...